摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | 1188335-77-4

中文名称
——
中文别名
——
英文名称
2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
英文别名
4-(4,4,5,5,-tetramethyl-1,3,2-dioxaborole)-2-tert-butylphenol;2-Tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)phenol
2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol化学式
CAS
1188335-77-4
化学式
C16H25BO3
mdl
——
分子量
276.184
InChiKey
XSUMAENGLSIWFW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    170-173 °C
  • 沸点:
    372.5±35.0 °C(Predicted)
  • 密度:
    1.03±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.99
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:7292ad9110c84cd625e86a4320376383
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    3,3′-Disubstituted bipolar biphenyls as inhibitors of nuclear receptor coactivator binding
    摘要:
    A series of bipolar biphenyl compounds was synthesized as proteomimetic analogs of the LXXLL pentapeptide motif responsible for the binding of coactivator proteins to the nuclear hormone receptor coactivator binding domain. These compounds were subjected to multiple in vitro assays to evaluate their effectiveness as competitive binding inhibitors. The results from this initial study indicate that these proteomimetics possess the ability to inhibit this protein-protein interaction. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.09.007
  • 作为产物:
    参考文献:
    名称:
    3,3′-Disubstituted bipolar biphenyls as inhibitors of nuclear receptor coactivator binding
    摘要:
    A series of bipolar biphenyl compounds was synthesized as proteomimetic analogs of the LXXLL pentapeptide motif responsible for the binding of coactivator proteins to the nuclear hormone receptor coactivator binding domain. These compounds were subjected to multiple in vitro assays to evaluate their effectiveness as competitive binding inhibitors. The results from this initial study indicate that these proteomimetics possess the ability to inhibit this protein-protein interaction. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.09.007
点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
    申请人:GiraFpharma LLC
    公开号:US20190023666A1
    公开(公告)日:2019-01-24
    Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
    提供了氨基吡嗪化合物作为腺苷受体的调节剂。这些化合物可能作为治疗经由G蛋白偶联受体信号通路介导的疾病的治疗剂,并且可能在肿瘤学中发挥特定作用。
  • Determining the Conformational Landscape of σ and π Coupling Using <i>para</i>-Phenylene and “Aviram–Ratner” Bridges
    作者:Daniel E. Stasiw、Jinyuan Zhang、Guangbin Wang、Ranjana Dangi、Benjamin W. Stein、David A. Shultz、Martin L. Kirk、Lukasz Wojtas、Roger D. Sommer
    DOI:10.1021/jacs.5b04629
    日期:2015.7.29
    donor-bridge-acceptor (D-B-A) electronic coupling matrix elements (H(DA), determined from the magnetic exchange coupling, J) involving a spin SD = 1/2 metal semiquinone (Zn-SQ) donor and a spin S(A) = 1/2 nitronylnitroxide (NN) acceptor mediated by the σ/π-systems of para-phenylene and methyl-substituted para-phenylene bridges and by the σ-system of a bicyclo[2.2.2]octane (BCO) bridge are presented and discussed
    供体-桥-受体 (DBA) 电子耦合矩阵元素 (H(DA),由磁交换耦合确定,J) 的扭转依赖性涉及自旋 SD = 1/2 属半醌 (Zn-SQ) 供体和自旋S(A) = 1/2 硝酰基硝基氧化物 (NN) 受体,由对亚苯基和甲基取代的对亚苯基桥的 σ/π 系统以及双环 [2.2.2] 辛烷 (BCO) 的 σ 系统介导) 桥进行了介绍和讨论。亚苯基桥上甲基的位置允许通过实验确定评估构象依赖性 (π) 和构象独立 (σ) 对这些 DBA 双自由基中 D 和 A 奇偶性的电子和磁交换耦合的贡献。 CASSCF 计算很好地描述了实验磁交换耦合的趋势。在将 DB 和 BA 扭转与电子和交换耦合相关的三维“拉马钱德兰型”图中进一步阐明了成对交换相互作用的扭转依赖性。对磁数据的分析表明,磁交换 (J ≈ 1-175 cm(-1)) 和电子耦合 (H(DA) ≈ 450-6000 cm(-1)) 的
  • Superexchange Contributions to Distance Dependence of Electron Transfer/Transport: Exchange and Electronic Coupling in Oligo(<i>para</i>-Phenylene)- and Oligo(2,5-Thiophene)-Bridged Donor–Bridge–Acceptor Biradical Complexes
    作者:Martin L. Kirk、David A. Shultz、Daniel E. Stasiw、Geoffrey F. Lewis、Guangbin Wang、Candice L. Brannen、Roger D. Sommer、Paul D. Boyle
    DOI:10.1021/ja4081887
    日期:2013.11.13
    The preparation and characterization of three new donor-bridge-acceptor biradical complexes are described. Using variable-temperature magnetic susceptibility, EPR hyperfine coupling constants, and the results of X-ray crystal structures, we evaluate both exchange and electronic couplings as a function of bridge length for two quintessential molecular bridges: oligo(para-phenylene), β = 0.39 Å(-1) and
    描述了三种新的供体-桥-受体双自由基配合物的制备和表征。使用变温磁化率、EPR 超精细耦合常数和 X 射线晶体结构的结果,我们评估交换和电子耦合作为两个典型分子桥的桥长度的函数:低聚(对亚苯基),β = 0.39 Å(-1) 和 oligo(2,5-噻吩),β = 0.22 Å(-1)。本报告首次对这些桥的交换/电子耦合和距离衰减参数 (β) 进行了直接比较。这项工作提供了对 β 的超交换贡献的直接测量,没有非相干跳跃的贡献。为低聚(对亚苯基)和低聚(2,5-噻吩)确定的不同 β 值主要是由于 DB 能隙 Δ,而不是桥桥电子耦合,H(BB)。从低聚(对亚苯基)(H(BB)= 11,400 cm(-1))和低聚(2,5-噻吩)(12,300 cm (-1)) 相差 <10%。这里呈现的结果提供了对控制 H(DA) 和 β 的内在分子因素的独特见解,这对于理解由分子桥介导的电子转移和电子传输的电子起源很重要。
  • Rules for Magnetic Exchange in Azulene-Bridged Biradicals: <i>Quo Vadis</i>?
    作者:Patrick Hewitt、David A. Shultz、Martin L. Kirk
    DOI:10.1021/acs.joc.1c02085
    日期:2021.11.5
    Electronic coupling through organic bridges facilitates magnetic exchange interactions and controls electron transfer and single-molecule device electron transport. Electronic coupling through alternant π-systems (e.g., benzene) is better understood than the corresponding coupling through nonalternant π-systems (e.g., azulene). Herein, we examine the structure, spectroscopy, and magnetic exchange coupling
    通过有机桥的电子耦合促进磁交换相互作用并控制电子转移和单分子器件电子传输。通过交替的π系统(电子耦合例如,苯)比更好地理解对应的贯通nonalternantπ系统(耦合例如,甘菊环)。在此,我们研究了两个双自由基(1,3-SQ 2 Az和1,3-SQ-Az-NN)的结构、光谱和磁交换耦合; SQ = 自旋 1/2 半醌自由基阴离子的 (II) 络合物,NN = 自旋 1/2 硝酰基硝基氧化物;Az = azulene) 具有非交替的 azulene π 系统桥。两个分子中的 SQ 自由基自旋密度离域到 Az π 系统,而 NN 自旋有效地定位到 NN 自由基的五原子 ONCNO π 系统上。自旋分布和相互作用通过 EPR 光谱和磁化率测量进行探测。我们发现对于1,3-SQ 2 Az J = +38 cm –1和对于1,3-SQ-Az-NN J = +9 cm –1 ()。我们的结果突出了由薁介导的交换耦合与由交替
  • PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
    申请人:PHENEX PHARMACEUTICALS AG
    公开号:US20140349987A1
    公开(公告)日:2014-11-27
    The invention provides modulators for the orphan nuclear receptor ROR γ and methods for treating ROR γ mediated diseases by administrating these novel ROR γ modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolo carboxamide compounds of Formula (1) and the enantiomers, diastereomers, N-oxides, tautomers, solvates and pharmaceutically acceptable salts thereof.
    该发明提供了用于孤儿核受体RORγ的调节剂,并通过向需要此类治疗的人或哺乳动物中施用这些新型RORγ调节剂的方法来治疗RORγ介导的疾病。具体而言,本发明提供了公式(1)的吡咯羧酰胺化合物及其对映体、二对映异构体、N-氧化物、互变异构体、溶剂化物和药学上可接受的盐。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫